Evidence map›Paper›PMID 42457021›Full record

ArticleThe Journal of investigative dermatology2026

Differential expression of immune checkpoint VISTA in inflammatory skin diseases.

Anjali Jaiswal, Eric Kim, Ümmügülsüm Yıldız-Altay, Rachel Breidbart, Michal Kidacki, William Damsky, Jennifer McNiff, Matthew D Vesely

Abstract read
In one paragraph

Article in The Journal of investigative dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anjali JaiswalDepartment of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA.
Eric KimDepartment of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA.
Ümmügülsüm Yıldız-AltayDepartment of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA.
Rachel BreidbartDepartment of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA.
Michal KidackiDepartment of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA.
William DamskyDepartment of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA; Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
Jennifer McNiffDepartment of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA; Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
Matthew D VeselyDepartment of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA. Electronic address: matthew.vesely@yale.edu.

Funding

Role of VISTA in discoid lupus erythematosusK08AR080777 · NIAMS · YALE UNIVERSITY · PI Matthew D Vesely · 2022 to 2026
$858k
NIAMS NIH HHS K08 AR080777
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cutaneous lupusImmune checkpoint agonistsLichen planusV-domain Ig suppressor of T-cell activation (VISTA)VSIR

Identifiers

PMID42457021
PMCPMC13458887

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.